pI: 4.9569 |
Length (AA): 414 |
MW (Da): 46136 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
32 | 257 | 1p5q (A) | 157 | 403 | 23.00 | 0.0000000000016 | 1 | 0.69 | 0.48 |
178 | 253 | 1na3 (A) | 9 | 84 | 36.00 | 0.000000034 | 1 | 0.84 | -2.1 |
138 | 288 | 4i2z (A) | 7 | 166 | 27.00 | 0.013 | 1 | 0.595134 | 0.33 |
138 | 255 | 2vyi (A) | 90 | 207 | 50.00 | 0 | 1 | 1.01262 | -1.59 |
200 | 255 | 4w9r (A) | 322 | 377 | 9.00 | 0 | 0.09 | 0.368866 | -1.66 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_128476)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G08320 | tetratricopeptide repeat domain-containing protein |
Brugia malayi | Bm1_56335 | TPR Domain containing protein |
Candida albicans | CaO19.13245 | related to human glu-rich tetratricopeptide repeat protein |
Candida albicans | CaO19.5823 | related to human glu-rich tetratricopeptide repeat protein |
Caenorhabditis elegans | CELE_R05F9.10 | Protein SGT-1 |
Dictyostelium discoideum | DDB_G0280345 | tetratricopeptide-like helical domain-containing protein |
Drosophila melanogaster | Dmel_CG5094 | small glutamine-rich tetratricopeptide containing protein |
Echinococcus granulosus | EgrG_000428500 | small glutamine rich tetratricopeptide |
Entamoeba histolytica | EHI_146980 | hypothetical protein, conserved domain containing |
Entamoeba histolytica | EHI_182700 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000428500 | small glutamine rich tetratricopeptide |
Giardia lamblia | GL50803_7287 | Small glutamine-rich tetratricopeptide repeat-containing protein |
Homo sapiens | ENSG00000197860 | small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
Homo sapiens | ENSG00000104969 | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
Leishmania braziliensis | LbrM.30.2700 | small glutamine-rich tetratricopeptide repeat protein, putative;with=GeneDB:LinJ30_V3.2470 |
Leishmania donovani | LdBPK_302740.1 | TPR domain protein, conserved |
Leishmania infantum | LinJ.30.2740 | small glutamine-rich tetratricopeptide repeat protein |
Leishmania major | LmjF.30.2740 | small glutamine-rich tetratricopeptide repeat protein, putative |
Leishmania mexicana | LmxM.29.2740 | TPR domain protein, conserved |
Loa Loa (eye worm) | LOAG_03987 | TPR Domain containing protein |
Mus musculus | ENSMUSG00000042743 | small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
Mus musculus | ENSMUSG00000004937 | small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
Oryza sativa | 4337495 | Os04g0690300 |
Saccharomyces cerevisiae | YOR007C | Sgt2p |
Schistosoma japonicum | Sjp_0097730 | IPR001440,Tetratricopeptide TPR_1;IPR013026,Tetratricopeptide region,domain-containing |
Schistosoma japonicum | Sjp_0130910 | expressed protein |
Schistosoma mansoni | Smp_065980 | heat shock protein 70 |
Schmidtea mediterranea | mk4.030668.00 | |
Schmidtea mediterranea | mk4.013496.02 | |
Trypanosoma brucei gambiense | Tbg972.6.3780 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.6.4000 | small glutamine-rich tetratricopeptide repeat protein, putative |
Trypanosoma congolense | TcIL3000_6_3410 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.511737.10 | small glutamine-rich tetratricopeptide repeat protein, putative |
Trichomonas vaginalis | TVAG_015860 | tetratricopeptide repeat protein, tpr, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.4000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.4000 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.4000 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.6.4000 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_R05F9.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_R05F9.10 | Caenorhabditis elegans | larval arrest | wormbase |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.